<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>Comments on: Paying Off Your Generic Drug Competition?  No Problem.</title>
	<atom:link href="http://www.patentbaristas.com/archives/2008/10/31/paying-off-your-generic-drug-competition-no-problem/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.patentbaristas.com/archives/2008/10/31/paying-off-your-generic-drug-competition-no-problem/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=paying-off-your-generic-drug-competition-no-problem</link>
	<description>Freshly Brewed Bio/Pharma Chat. Served Up Daily.</description>
	<lastBuildDate>Tue, 07 Feb 2012 11:57:58 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Patent Baristas &#187; FTC Sues Drug Company for Paying Competitors to Delay Generic Launch</title>
		<link>http://www.patentbaristas.com/archives/2008/10/31/paying-off-your-generic-drug-competition-no-problem/comment-page-1/#comment-65511</link>
		<dc:creator>Patent Baristas &#187; FTC Sues Drug Company for Paying Competitors to Delay Generic Launch</dc:creator>
		<pubDate>Tue, 03 Feb 2009 22:55:19 +0000</pubDate>
		<guid isPermaLink="false">http://www.patentbaristas.com/archives/2008/10/31/paying-off-your-generic-drug-competition-no-problem/#comment-65511</guid>
		<description>[...] to abandon their patent challenges and agree to delay generic entry until 2015 (known as &#8220;reverse payments&#8220;). As a result, the complaint states that the defendants are cooperating on the sale of [...]</description>
		<content:encoded><![CDATA[<p>[...] to abandon their patent challenges and agree to delay generic entry until 2015 (known as &#8220;reverse payments&#8220;). As a result, the complaint states that the defendants are cooperating on the sale of [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Served from: www.patentbaristas.com @ 2012-02-12 20:59:40 -->
